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Context: Self-limited delayed puberty (DP) segregates in an autosomal-dominant pattern, but the
genetic basis is largely unknown. Although DP is sometimes seen in relatives of patients with
hypogonadotropic hypogonadism (HH), mutations in genes known to cause HH that segregatewith
the trait of familial self-limited DP have not yet been identified.
Objective: To assess the contribution of mutations in genes known to cause HH to the phenotype of
self-limited DP.
Design, Patients, and Setting:Weperformedwhole-exome sequencing in 67 probands and 93 relatives
from a large cohort of familial self-limited DP, validated the pathogenicity of the identified gene variant
in vitro, and examined the tissue expression and functional requirement of the mouse homolog in vivo.
Results:Apotentially pathogenic gene variant segregatingwith DPwas identified in 1 of 28 knownHH
genes examined. This pathogenic variant occurred in HS6ST1 in one pedigree and segregated with the
trait in the six affectedmemberswith heterozygous transmission (P = 3.013 1025). Biochemical analysis
showed that this mutation reduced sulfotransferase activity in vitro. Hs6st1 mRNA was expressed in
peripubertal wild-type mouse hypothalamus. GnRH neuron counts were similar in Hs6st1+/2 and
Hs6st1+/+mice, but vaginal openingwas delayed inHs6st1+/2mice despite normal postnatal growth.
Conclusions:We have linked a deleterious mutation in HS6ST1 to familial self-limited DP and show
that heterozygous Hs6st1 loss causes DP in mice. In this study, the observed overlap in potentially
pathogenic mutations contributing to the phenotypes of self-limited DP and HH was limited to this
one gene. (J Clin Endocrinol Metab 103: 3420–3429, 2018)
Abnormal pubertal timing affects.4%of adolescentsand is associated with adverse health and psycho-
social outcomes (1–3). However, in most patients with
early or late onset of puberty, the underlying patho-
physiology is unknown. Self-limited delayed puberty
(DP) represents an extreme variant of normal pubertal
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timing and has been shown to cluster in families (4).
Several groups have noted that DP segregates in an
autosomal-dominant pattern (4, 5), suggesting monogenic
or oligogenic inheritance conferred by haploinsufficiency
or a gain-of-function mutation. As such, pedigrees with
familial DP represent an invaluable resource to investigate
the genetic regulation of puberty onset.
Significant insights into the genetic control of the
hypothalamic–pituitary–gonadal (HPG) axis have come
from the discovery of rare variants underlying conditions
of GnRH deficiency, such as hypogonadotropic hypo-
gonadism (HH) (6). Perturbed embryonic migration of
GnRH neurons from the nose to hypothalamus has been
shown to cause HH in humans and in animal models (7,
8). Alternatively, HH may arise through mutations that
affect GnRH secretion or function in the presence of a
normal GnRH neuron number in the hypothalamus (9).
In view of the possible overlap between the patho-
physiology ofDP and conditions of GnRHdeficiency, a few
studies have examined the contribution of mutations in
genes that cause HH to the pathogenesis of DP (10–12).
Potentially pathogenic variants in a small number of genes
causing HH (GNRHR, TAC3, TACR3, IL17RD, and
SEMA3A) were identified by whole-exome sequencing
(WES) in a few cases of self-limitedDP, including thosewith
constitutional delay of growth and puberty (13).Moreover,
evidence from WES in our own cohort supports the hy-
pothesis that mutations in genes that influence GnRH
neuronal migration or development can cause self-limited
DP (14). In this study, we assessed the contribution of
mutations in genes known to causeHH to the phenotype of
familial self-limited DP and have identified a heterozygous
HS6ST1 mutation as a novel cause of self-limited DP.
Methods
Patients
The patients selected for this study belong to a previously
described and accurately phenotyped Finnish DP cohort, for
which diagnosis is based on objective evidence of a delayed pu-
bertal growth spurt rather than self-recall (15). Patients were
referredwithDP to specialist pediatric care in central and southern
Finland from 1982 to 2004. All patients (n = 492) met the di-
agnostic criteria for self-limited DP, defined as the onset of Tanner
genital stage II (testicular volume.3 mL).13.5 years in boys or
Tanner breast stage II .13.0 years in girls (i.e., 2 SD later than
average pubertal development) (16). Medical history, clinical
examination, and routine laboratory tests were reviewed to ex-
clude those with chronic illness. HH, if suspected, was excluded by
spontaneous pubertal development at follow-up. Normal fertility
has been demonstrated in affected family members (5). Families of
the DP patients were invited to participate via structured in-
terviews and using archived height measurement records. The
criteria for DP in probands’ family members were: (1) age at take-
off; or (2) peak height velocity occurring 1.5 SD beyond the mean,
that is, age at take-off.12.9 and 11.3 years, or age at peak height
velocity .14.8 and 12.8 years in males and females, respectively;
or (3) age at attaining adult height .18 or 16 years in males and
females, respectively (15). Written informed consent was obtained
from all participants. The study protocol was approved by the
Ethics Committee for Pediatrics, Adolescent Medicine and Psy-
chiatry, Hospital District of Helsinki andUusimaa (570/E7/2003).
UK ethical approval was granted by the London–Chelsea Na-
tional Research Ethics Service committee (13/LO/0257). The study
was conducted in accordance with the guidelines of the Decla-
ration of Helsinki.
Genetic analysis
Genetic analysis was performed in 67 probands with DP
from those 67 families with the greatest number of affected
individuals in our cohort (male, n = 57; female, n = 10, see
Supplemental Fig. 1), 58 affected family members (male, n =
36; female, n = 22), and 35 of their unaffected family members
(male, n = 13; female, n = 22). WES was performed on DNA
extracted from peripheral blood leukocytes of these 160 in-
dividuals, using a Nimblegen v.2 or Agilent v.5 platform and
Illumina HiSeq 2000 sequencing. The exome sequences were
aligned to the University of California Santa Cruz hg19 ref-
erence genome. Picard tools and the Genome Analysis Toolkit
were used to mark PCR duplicates, realign around indels,
recalibrate quality scores, and call variants.
Variants were analyzed and filtered for potential causal variants
using filters for quality control, predicted function, minor allele
frequency (MAF), and biological relevance (Fig. 1). Filtering by
MAF included only variants withMAF,1% in the 1000Genomes
database, the National Heart, Lung, and Blood Institute exome
variant server, and the ExAC and gnomAD databases. Biological
relevance filtering allowed prioritization of variants according to
our “HH genes” list (Table 1), comprising genes known to be
relevant to the phenotype of HH based on previously published
studies and using pathway analysis with MetaCore (GeneGo/
Thomson Reuters). The segregation with trait filter retained only
variants present in $n 2 1 affected individuals (where n indicates
the number of affected individuals in a given pedigree) and not
present in more than one unaffected individual (Table 1).
Targeted exome sequencing (Fluidigm) of the remaining
candidate gene postfiltering was performed in a further 42
families from the same cohort (288 individuals, 178 with DP:
male, n = 106; female, n = 72; and 110 controls: male, n = 55;
female, n = 55; Fig. 1), with filtering as in Howard et al. (14).
Whole-gene rare variant burden testing was performed after
sequencing. A Fisher’s exact test was used to compare the
prevalence of deleterious variants in our cohort with the Finnish
population, using the ExAC browser (Exome Aggregation
Consortium, Cambridge, MA). For each gene, all variants from
the ExAC database with minor allele frequency ,2.5%, pre-
dicted to be deleterious by both Polyphen-2 (17) and SIFT (18),
were included in the analysis, with each family in our cohort
represented by the proband only. A multiple comparison ad-
justment was applied post hoc using the Benjamini–Hochberg
method (19), as detailed in Howard et al. (14). All variants
identified were confirmed via Sanger sequencing.
In vitro assay of sulfotransferase activity
The human HS6ST1 cDNA (IMAGE consortium accession ID
BC099638)was obtained fromGeneCopoeia in a pReceiverM14a
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backbone (pReceiverM14a-WThHS6ST1). The p.Arg375His
and p.Met404Val point mutations were introduced by PCR-
mediated mutagenesis (QuickChange II, Agilent Technol-
ogies), using the following primers: Hs6st1_R375H_FOR,
50-GCCTGAGGAGCCACGAGGAGCGTCT-30, Hs6st1_
R375H_REV 50-AGACGCTCCTCGTGGCTCCTCAGGC-30
for p.Arg375His; and Hs6st1_M404V_FOR, 50-CCCACCGAG-
GACTACGTGAGCCACATCATTG-30, Hs6st1_M404V_REV,
50-CAATGATGTGGCTCACGTAGTCCTCGGTGGG-30 for
p.Met404Val. Mutations were confirmed by Sanger se-
quencing. COS7 cells, at 90% confluency in six-well plates,
were transfected with 2 mg of wild-type (WT) or mutant
plasmids using FuGENE HD (Promega). After 48 hours, cells
were lysed with 50 mM Tris-HCl, 150 mM NaCl, 1 mM
EDTA, and 1% Triton X-100 (pH 7.4). The homogenates
were stirred for 1 hour and then centrifuged at 10,0003 g for
30 seconds at 4°C to clear debris. HS6ST1-FLAG fusion
proteins were isolated from the supernatant using an anti-
FLAG M2 affinity chromatography kit (A2220, Sigma-
Aldrich). The purity of the eluted protein was checked by
Coomassie brilliant blue (Thermo Fisher) staining of SDS-
PAGE electrophoretic gels. Protein relative amounts were
calculated by densitometric analysis of Western blots with
mouse monoclonal M1 anti-FLAG antibody (1:1000
dilution, Sigma-Aldrich).
Sulfotransferase activity was measured using R&D Sys-
tems’ colorimetric assay (EA003). Briefly, different amounts
of purified HS6ST1 proteins were added to a mix of 0.2 mM
30-phosphoadenosine-50-phosphosulfate (do-
nor), 1 mM N-acetylglucosamine (acceptor),
and 10 ng/mL inositol monophosphatase 3
(coupling enzyme) in a total volume of
50 mL of reaction buffer. The elution
product of mock-transfected cells was
used as negative control. The reaction was
allowed to proceed for 20 minutes at 37°C
with inorganic phosphate measured im-
mediately after by the malachite green
method. Enzymatic activity was repre-
sented as percentage of WT activity.
Animals
Animal procedures were performed
in accordance with institutional and UK
Home Office guidelines. The Hs6st1+/2
mice have been described previously (20,
21) and were maintained on a C57BL/6J
background by pairing with WT partners.
Hs6st1+/+ and Hs6st1+/2 female mice were
checked daily for vaginal opening (VO) and
weight after weaning, that is, from 21 days
of age (22).
Histological analyses
Peripubertal and adult mice were per-
fused with 4% formaldehyde in PBS and
then brains and testis were dissected and
postfixed overnight at 4°C. Testes were
dehydrated, embedded in paraffin, micro-
tome sectioned at 8 mm. and stained with
hematoxylin and eosin, as previously de-
scribed (23). For in situ hybridization (ISH)
or immunostaining, brains were cryoprotected in 30% sucrose
and frozen in OCT compound (VWR). Twelve-micrometer-
thick serial sagittal and coronal cryosections were collected on
Superfrost Plus slides (VWR) and incubated with antisense
riboprobes for Gnrh (24) or Hs6st1 (21). In some experiments,
we combined ISH with GnRH immunofluorescence and used a
different mouse Hs6st1 probe, which was generated by PCR
amplification from brain cDNA using 50-ACTGGACC-
GAACTCACCAAC-30 and 50-AACTCAGTGAGGCCGAA-
GAA-30 as primers and cloning into the dual promoter vector
pGEM-T easy (Promega). Probes were generated as described
(25). For immunoperoxidase staining, mouse 25-mm mouse
brain cryosections were incubated with Bloxall (Vector Labo-
ratories) to quench endogenous peroxidase activity before
incubation with GnRH primary antibody (1:1000 in PBS,
ImmunoStar) followed by incubation with biotinylated goat
anti-rabbit antibody (1:400 in PBS; Vector Laboratories). Im-
munostaining was developed with the ABC kit (Vector Labora-
tories) and diaminobenzidine (Sigma-Aldrich), as described (24).
Image processing and quantification
Images were acquired either using a Leica DM5500B mi-
croscope equipped with a DCF295 camera and DCViewer
software (Leica) and then processed with Photoshop CS6 and
Illustrator CS6 (Adobe) or acquired on an Axioskop 2 Plus
microscope (Zeiss) equipped with a TCH-5.0 ICE digital
camera (TiEsseLab). In some experiments, bright-field images
of ISH patterns were converted to RGB color mode for
Figure 1. Flowchart of WES filtering strategy to identify HS6ST1. WES was performed on
DNA extracted from peripheral blood leukocytes of 160 individuals from our cohort (67 DP
probands, 58 DP relatives, and 35 controls). The exome sequences were aligned to the
University of California Santa Cruz hg19 reference genome. Picard tools and the Genome
Analysis Toolkit were used to mark PCR duplicates, realign around indels, recalibrate quality
scores, and call variants. Potential causal variants were identified using filters for quality
control, predicted functional annotation, MAF, biological relevance (i.e., “HH gene” list), and
segregation with trait (see Methods and Table 1 for further information on filtering criteria).
Targeted exome sequencing using a Fluidigm array of one candidate gene was then
performed in a further 42 families from the same cohort (288 individuals, 178 with DP and
110 controls). Variants identified via targeted resequencing were filtered using the same
criteria as the WES data, with additional rare variant burden testing. Functional annotation
of the variants is as described in “Methods.”
3422 Howard et al HS6ST1 Mutation in Self-Limited Delayed Puberty J Clin Endocrinol Metab, September 2018, 103(9):3420–3429
D
ow
nloaded from
 https://academ
ic.oup.com
/jcem
/article-abstract/103/9/3420/5040368 by guest on 31 January 2019
superimposition onto fluorescent images. GnRH-positive cells
were counted on fifty 25-mm sections through the entire medial
preoptic area (MPOA) of each animal. To compare the
abundance of GnRH-positive neurites at the median eminence
(ME), we measured the pixel intensity of GnRH staining in
25-mm-thick coronal sections through the entire ME.
Statistical significance
Data are expressed as mean 6 SEM. Differences between
groups were evaluated by a two-tailed student t test and con-
sidered significant at P , 0.05. Statistical analysis was per-
formed using Prism (GraphPad Software).
Results
Exome sequencing of families with self-limited DP
identified an HS6ST1 variant
WES of 67 informative families from our large cohort
with self-limited DP identified 20 rare (MAF ,1%) and
predicted deleterious variants in 12 genes from a list of
known HH genes (Table 1). However, after filtering for
segregation with trait, onlyHS6ST1 (ENSG00000136720,
gene ID number 9394) was retained as a candidate gene
(Fig. 1). One proband and his affected relatives from
one pedigree sequenced carried a rare and likely
damaging HS6ST1 variant [NM_004807.2: c.1124G.A
(rs182882999) p.Arg375His] that causes a nonconser-
vative amino acid substitution in the coding sequence. This
proband carried an additional potentially pathogenic
variant in a known HH gene, FEZF1 (NM_ NM_
001024613.3: c.1010T.A, p.Iso337Lys). However, this
variant was not found in any other affected individual
from this family andwas, therefore, discounted due to lack
of familial segregation.
The rare heterozygous missense variant HS6ST1
(p.Arg375His) is predicted to be deleterious to protein
function with five of six prediction tools, as the affected
amino acid residue resides in a coiled-coil domain that is
highly conserved among species, as revealed by the PhyloP
and GERP score and a multiple sequence alignment
(Supplemental Fig. 2 and Supplemental Table 1). This
specific variant was present at low MAF in some public
databases, but whole-gene rare variant burden testing
showed significant enrichment of HS6ST1 rare predicted
pathogenic variants in our cohort as compared with
ethnically matched controls from the ExAC database
(adjusted P = 3.01 3 1025).
After targeted exome sequencing, two additional
variants in HS6ST1 were identified in three further
affected probands [NM_004807.2: c199A.T(rs202247387)
p.Lys67* and c585G.A p.Trp195*]. However, Sanger se-
quencing did not validate the existence of these vari-
ants. No further rare, potentially damaging, and trait-
segregating variants in HS6ST1 were identified by
targeted sequencing.
Pedigree with a potentially pathogenic HS6ST1
variant displayed an autosomal-dominant
inheritance pattern and classical self-limited DP
The pedigree with the p.Arg375His variant has several
family members with typical features of self-limited DP
(Fig. 2A). The proband was first investigated for growth
delay at 12.8 years, at which time his bone age was
11 years (Fig. 2B). Examination at this stage found him to
be prepubertal, with bilateral testis volumes of 2 mL and
no pubic hair development. His blood biochemistry at that
time showed a typical picture of functional HH. Spon-
taneous onset of puberty was observed at ;14.3 years of
age. During the next 2.4 years, he achieved testis volume
and testosterone levels within the normal adult range. His
sister’s age at menarche was 15 years. Both siblings had
normal birth weight and birth length. Their father and
paternal uncle and aunt also hadDPwith delayed pubertal
Table 1. HH Gene Filtering
Gene
No. of Rare and Predicated Damaging Variants
Filtered From WES Data
Not Segregating With
the DP Trait
Segregating With the
DP Trait
ANOS1 0 0
AXL 3 0
CHD7 3 0
DAX1 0 0
FEZF1 3 0
FGF8 0 0
FGFR1 2 0
GNRH1 0 0
GNRHR 0 0
HESX1 0 0
HS6ST1 1 1
KISS1 0 0
KISS1R 0 0
LEP 0 0
LEPR 0 0
LHX3 1 0
LHX4 1 0
NELF 0 0
PCSK1 0 0
PROK2 0 0
PROKR2 2 0
PROP1 1 0
SEMA3A 0 0
SF1 0 0
SPRY4 1 0
TAC3 1 0
TAC3R 0 0
WDR11 1 0
Twenty-eight HH genes, mutations in which have been identified as
causal or potentially causal in patients with GnRH deficiency, used for
filtering after WES are shown. Details are given of number of variants in
these genes identified in 67 probands with DP after WES. Variants are
divided into those that were found to segregate with the DP trait within
cohort pedigrees and those that did not segregate.
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growth spurt. All family members with
DP had self-reported normal olfaction.
The HS6ST1 p.Arg375His
mutant protein has reduced
sulfotransferase activity in vitro
In vitro analysis of sulfotransferase
function of the p.Arg375His mutant
HS6ST1 protein (Fig. 2C) showed re-
duced activity at 39% of the WT
HS6ST1 protein (mean 6 SD: 39.81 6
8.21, P , 0.001). This reduction in
enzymatic function is within the range
seen with other pathogenic mutations in
HS6ST1 found in patients with HH (26)
and similar to that of the p.Met404Val
mutant HS6ST1 protein (mean 6 SD:
28.8 6 1.46). This observation is con-
sistent with the HS6ST1 p.Arg375His
mutation as causative in self-limited DP.
Hs6st1 is expressedwithin the adult
hypothalamus and olfactory bulbs
In the adult brain, GnRH neurons
are scattered in a bilateral continuum
between the olfactory bulb (OB) and
the MPOA of the hypothalamus,
where most cell bodies reside (27). We
found that Hs6st1 is highly expressed
in the granular, mitral, and glomerular
layers of the adult OB (Fig. 3A) and
diffusely in the MPOA (Fig. 3B, upper
panel). Hs6st1 expression was also
observed in the arcuate nucleus (ARC),
which harbors neurons that regulate
GnRH secretion (Fig. 3B, lower panel).
However, Hs6st1 mRNA did not lo-
calize to GnRH+ neurons (Fig. 3C).
These observations suggest thatHs6st1
is expressed by hypothalamic cells that
do not correspond to GnRH neurons.
Normal positioning and number of
GnRH neurons in the MPOA of
Hs6st1 heterozygous mice
To determine whether HS6ST1 is
required for the normal development
of the GnRH neuron system, we com-
pared mice heterozygous for a Hs6st1
null allele (Hs6st1+/2) to their WT lit-
termates (Hs6st1+/+). However, there
were no gross differences in brain or
OB anatomy between the genotypes
Figure 2. Pedigree and clinical details of a patient with a p.Arg375His mutation in HS6ST1 that
impairs sulfotransferase activity. (A) Pedigree of the proband with the p.Arg375His mutation.
Squares indicate male family members; circles indicate female family members. Black symbols
represent clinically affected family members, gray symbols represent family members with
unknown phenotype, and clear symbols represent unaffected individuals. The arrow labeled “P”
indicates the proband in the family. A horizontal black line above or adjacent to an individual’s
symbol indicates that they are heterozygous for the p.Arg375His mutation as identified by either
WES or Fluidigm array and verified by Sanger sequencing. (B) Clinical details of the proband with
the p.Arg375His mutation. Height chart for the proband shows reduction in growth velocity
from 12 y of age, with associated delayed bone age shown in red. The subject was prepubertal
until 14.1 y of age. This was followed by spontaneous onset of puberty and subsequent
development during 2 y to normal adult testosterone levels and testicular volume. (C)
Sulfotransferase activity assay. The p.Arg375His mutation reduces HS6ST1 sulfotransferase
activity. Relative specific activity (mean 6 SD) of recombinant WT or mutant (p.Arg375His
or p.Met404Val) HS6ST1 proteins are shown. All assays were done as three independent
biological repeats (n = 3 for each experiment) using equal amounts of protein. ***P , 0.001.
G, Tanner genital stage, Ph, Tanner pubic hair stage, T, testosterone; T vol, testicular volume.
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(Fig. 4A and 4B). Moreover, there were no obvious
differences in the positioning and number of GnRH
neurons in the MPOA (Fig. 4C and 4D; number of
GnRH+ cells: Hs6st1+/2 341.2 6 24.2 vs Hs6st1+/+
378.3 6 30.2, n = 5 each; P = 0.37). GnRH neurons in
Hs6st1+/2 mice also projected similarly to the ME, the
site where they normally release GnRH into the portal
blood vessels of the pituitary gland; moreover, the pixel
intensity of GnRH-stained neurites was similar in both
genotypes (Fig. 4E and 4F; percentage stained neurite
area: Hs6st1+/+ 2.9 6 0.4 vs Hs6st1+/2 3.1 6 0.3, n = 5
each; P = 0.09).
Hs6st1+/2 mice show significant DP onset
To determine whether heterozygous HS6ST1 deficiency
is sufficient to causeDP, we compared the timing of puberty
in Hs6st1+/2 and Hs6st1+/+ female mice by identifying the
day of VO, a proxy measurement for pubertal activation of
the HPG axis in mice (22). We found that VO was delayed
by on average 1.88 6 0.82 days in Hs6st1+/2 compared
with Hs6st1+/+ females (Fig. 5A, left; postnatal day (P) of
VO:Hs6st1+/+ 30.26 0.7, n = 12, vsHs6st1+/2 31.96 0.5,
n = 13; P = 0.04; mice were pooled form six different
litters). DP in Hs6st1+/2 females was not due to overall
delayed development, as they were not smaller than
Hs6st1+/+ littermate females around the time of VO
(weight at P30: Hs6st1+/+ 14.12 6 0.58 g, n = 12, vs
Hs6st1+/213.676 0.58 g, n = 13; P = 0.29). Instead, and
consistent with their DP and thus older age at VO in the
Hs6st1+/2 females, there was an insignificant trend
toward greater weight at the time of VO in Hs6st1+/2
compared with Hs6st1+/+ females within the cohort
examined (Fig. 5A, right; body weight on the day of VO:
Hs6st1+/+14.96 0.3 g, n = 12, vsHs6st1+/2 15.56 0.3 g,
n = 13; P = 0.06).
Despite DP, the fertility of young adultHs6st1+/2 males
and females of both sexes appeared normal, because they
produced litters without obvious delay and of normal litter
size when paired to WTmice at 4 to 6 months of age (litter
size:Hs6st1+/23Hs6st1+/+: 7.26 0.95 pups per litter in six
litters, vsHs6st1+/+3Hs6st1+/+ 7.36 0.71 pups per litter in
seven litters; P = 0.89; Hs6st1+/2 mice were born at the
expected Mendelian ratio). In agreement with the ability to
father litters of normal size, testes size was similar in
young adult Hs6st1+/2 and Hs6st1+/+ males (Fig. 5B;
P35 testes length (in mm):Hs6st1+/2 8.306 0.16, n = 6,
vs Hs6st1+/+ 8.31 6 0.17, n = 8; P = 0.97). Moreover,
testes showed normal organization of germ cells and
interstitial Leydig cells and contained a similar number
of seminiferous tubules per area (Fig. 5B and 5C;
number of seminiferous tubules per mm2: Hs6st1+/+
14.536 0.91 vsHs6st1+/2 14.696 0.62; n = 5 each; P =
0.88). Taken together, these findings show that HS6ST1
haploinsufficiency delays puberty in mice without com-
promising fertility in the adult.
Discussion
The inheritance of self-limited DP is under strong genetic
influence, with clear autosomal-dominant segregation in
Figure 3. Hs6st1 mRNA expression in GnRH neuronal territories on
P35. (A) Coronal sections of adult mouse OB were labeled for
Hs6st1 by ISH. The squared box in the left image is shown at
higher magnification to the right. (B) Contiguous coronal sections of
adult mouse hypothalamus representing the MPOA (upper panels)
and the ME (lower panels) were labeled for Gnrh and Hs6st1 by
ISH; arrowheads indicate the Hs6st1 expression in the ARC and ME.
(C) Hs6st1 ISH (green) of coronal sections from P35 MPOA followed
by immunolabeling for GnRH (red) revealed no expression of Hs6st1
in GnRH-positive neurons (example of GnRH neuron is indicated
with a solid arrowhead). Scale bars: 125 mm (A and B, upper
panels), 50 mm (B, lower panels), 25 mm (C). 3v, third ventricle;
GL, glomerular layer; GR, granular layer; MI, mitral layer.
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many families with or without complete penetrance (4),
and thus represents a useful basis for the investigation of
puberty genetics (5). However, only a few genes re-
sponsible for self-limited DP have been identified. In view
of the possible overlap between the pathophysiology of
DP and HH, screening self-limited DP patients for mu-
tations in known HH genes appears a prudent strategy;
however, minimal genetic overlap between the two
conditions has been identified to date (13). Additionally,
there have been some observed differences in inheritance
patterns and penetrance between the two conditions
(28). In HH, .40 different genes have been identi-
fied, and incomplete penetrance is often seen within
pedigrees, leading to a wide spectrum
of phenotypes (29–31). As the un-
derstanding of the genetic basis of both
self-limited DP and HH improves, it is
likely that genetic testing will be able to
help establish a definitive diagnosis in
adolescent patients presenting with
delayed onset of puberty.
In this study, we have identified a
deleterious mutation, p.Arg375His, in
the HH gene HS6ST1 as the likely
causal factor for self-limited DP in one
pedigree from our cohort of patients
with familial DP.
HS6ST1 mutations have been pre-
viously identified in up to 2% of patients
with idiopathic HH (26, 32), but they
have not previously been reported in
pedigrees segregating with the trait of
self-limited DP. Our in vitro analysis
showed that the HS6ST1 p.Arg375His
mutation had reduced sulfotransferase
activity, comparable to previously pub-
lished mutations in this gene in patients
with HH (26). Taken together, these
results suggest a workingmodel in which
HS6ST1heterozygosity causes self-limited
DP, whereas potentially HS6ST1 ho-
mozygosity or a “second hit” in a sep-
arate genewould produce the phenotype
of HH.
Our studies in a murine model
corroborate heterozygous Hs6st1 de-
ficiency as a cause of delayed pubertal
timing without compromised fertility.
Thus, Hs6st1+/2 mice were born at
normal Mendelian ratios without ob-
vious defects in GnRH neuron or testes
development, but females showed
delayed VO. The question of sex bias
in self-limited DP is an interesting one, as it is diagnosed
in up to 83% of boys and 30% of girls presenting with
pubertal delay (33–35). The underlying reasons for this
sex difference are not clear. However, this difference may
be due, in part, to ascertainment bias. Indeed, a previous
study has shown a nearly equal sex ratio consistent with
autosomal-dominant inheritance when all of the affected
individuals from our large cohort were examined, as
opposed to the probands only (5).
In our murine model of Hs6st1+/2 mice, we did not
find any evidence of a sex difference in anatomical
studies. In this study only females were examined for
timing of pubertal onset (VO), as VO is a very robust
Figure 4. Hs6st1+/2 mice showed no defects in olfactory bulbs or in the number and
projections of GnRH neurons. (A and B) Perfused adult Hs6st1+/+ and Hs6st1+/2 brains were
dissected, photographed, and showed similar olfactory bulb structure in both genotypes. (C
and D) Coronal sections of adult mouse MPOA were immunostained for GnRH; arrowheads
indicate examples of GnRH neurons that are normally present both in Hs6st1+/2 and WT
mice. (E and F) Immunostaining for GnRH in coronal sections of adult mouse ME shows that
GnRH neurons project similarly to the ME in Hs6st1+/+ and Hs6st1+/2 mice. Scale bars: 3 mm
(A and B), 125 mm (C and D), 50 mm (E and F). Arrows demonstrate representative GnRH
cell bodies. 3v, third ventricle.
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marker of pubertal onset in female mice. Male mice were
not assessed for the timing of puberty, but the adult male
mice had normal testicular morphology, including the
presence of spermatogenesis. Normal spermatogenesis is
an excellent marker in males for reproductive compe-
tence and excludes GnRH deficiency. In female mice the
reproductive competence was assessed as fertility of the
females. With these methods GnRH deficiency was ex-
cluded both in male and female Hs6st1+/2 mice. Im-
portantly, mice deficient inHs6st1 were not significantly
smaller or lighter than their WT littermates, excluding
poor growth as the underlying cause for pubertal delay.
The viability of Hs6st1+/2 mice is in contrast to that of
Hs6st1 knockout (Hs6st12/2) mice, which could not
be examined for puberty defects due to embryonic
lethality (36).
Our expression studies in mice indicate that Hs6st1 is
expressed in several tissues relevant to normal GnRH
neuron migration or function, including the OB and the
MPOA, ARC, and PVN of the hypothalamus. However,
we did not identify any obvious abnormalities in OB
morphology, GnRH neuron number in the MPOA, or in
GnRH neuron innervation of the ME in Hs6st1+/2 mice.
Instead, Hs6st1 expression in the ARC and PVN, where
kisspeptin neurons and tanycytes modulate GnRH se-
cretion and function (37, 38), raises the possibility that
HS6ST1 haploinsufficiency affects the regulation of GnRH
neuron activity or other relevant downstream pathways.
Hs6st1 is required for the function of Anos1 (also
known as Kal1) and Fgfr1, two genes that are required
for normal HPG axis function (26). In a Caenorhabditis
elegans model, Hs6st1 regulates neural branching in
concert with Anos1 and Fgfr1 (26). Moreover, Anos1 is
also able to enhance Fgfr1 signaling in an HS-dependent
manner in an immortalized human cell model of GnRH
neurons, and it has been proposed that this interaction
promotes olfactory andGnRHneuron development (39).
However, Hs6st1 mutations may also impact the HPG
Figure 5. Peripubertal female Hs6st1+/2 mice show delayed VO whereas young adult male Hs6st1+/2 mice showed normal testes morphology.
(A) Age (left graph) and weight (right graph) at the time of the VO in female Hs6st1+/+ (n = 12) and Hs6st1+/2 (n = 13) mice. Values for
littermates are shown in the same color. *P , 0.05. (B and C) Hs6st1+/+ and Hs6st1+/2 mice have similar testes size (B, upper panels), normal
spermatogenesis after H&E staining of paraffin sections (B, lower panels), and similar number of seminiferous tubules (C). Scale bars: 3 mm (B,
upper panels), 25 mm (B, lower panels).
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axis via Anos1-independent pathways, as HS modifica-
tions of many different proteoglycans in the extracellular
matrix have the potential to affect multiple signaling
pathways (40) previously implicated in the neuroendo-
crine control of fertility (41).
In summary, we have identified a new pathogenic
mutation in HS6ST1 as the likely cause of DP in a
pedigree from our extensive patient cohort, with no other
pathogenic mutations in genes known to cause HH
identified in our cohort. These findings suggest that, with
the exception of a few genes like HS6ST1, the genetic
background of HH and DP is either largely different or is
due to mutations in as yet undiscovered genes. Our
findings differ from those in previous publications, in
which up to 14% of DP probands were reported to carry
potentially pathogenic variants in HH genes (13).
However, previous results have not been adjusted for
segregation with the DP trait within families, nor have the
variants identified in these previous studies been tested
for pathogenicity, and thus prior estimates of HH mu-
tation rates in DP patients may have been an over-
estimation. In agreement, prior to adjustment for
segregation, our results suggested that 17.9% of DP
probands had potentially pathogenic variants in HH
genes, highlighting the value of familial data in identi-
fication of causal variants in a condition such as DP.
Although further pedigrees with familial DP need to be
studied to identify additional causative genes and provide
accurate estimates of the genetic HH andDP overlap, our
findings provide evidence that perturbations in a single
allele of a gene regulating the HPG axis is sufficient to
cause self-limited DP. In contrast, available evidence
suggests that more deleterious alterations in the same
gene, or in combination with additional genes, are re-
quired to cause more severe HH phenotypes.
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